Stocks · News reference
Twist Bioscience Corporation shares declined following the release of a critical report by The Bear Cave and Hunterbrook.
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Twist Bioscience Corp (NASDAQ:TWST) shares are plunging Thursday. The Bear Cave, which Hunterbrook Media owns, said that the life science tools company's stock price may have run ahead of its fundamentals. Here's what you should know.
Twist Bioscience Corporation has issued a summary notice regarding a proposed settlement in a derivative action pending in the U.S. District Court for the District of Delaware.
Ark Invest reduced its position in Twist Bioscience, selling $7.3 million worth of shares on November 2, 2026.
Twist Bioscience has introduced a new express screening antibody service to expand its production and characterization portfolio.
Twist Bioscience has introduced Twist MRD Express, a new line of custom panels designed for rapid, high-throughput molecular residual disease (MRD) research in oncology.